AvenCell Therapeutics
AvenCell Therapeutics is a clinical-stage cell therapy company focused on developing autologous and allogeneic switchable CAR-T cell therapies. Their proprietary universal platform allows for the safe and effective treatment of hematologic malignancies and autoimmune diseases by enabling rapid on/off switching of CAR-T cells even after administration. This technology addresses unmet medical needs in areas like relapsed/refractory AML.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $112M
Date: 22-Oct-2024
Investors: Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures, Blackstone Life Sciences
Markets: Cell Therapy, Oncology, Immunology, Health Care
HQ: Watertown, Massachusetts, United States
Founded: 2021
Website: https://www.avencell.com/
LinkedIn: https://www.linkedin.com/company/avencell/
Crunchbase: https://www.crunchbase.com/organization/avencell
Leave a Comment
Comments
No comments yet.